Table 1.
Patients characteristics at inclusion.
| Characteristic | EU-HGS (n = 31) | PTDB (n = 20) | p |
|---|---|---|---|
| Age, mean (SD), years | 69.2 | 67.7 | 0.55 |
| Sex | 0.40 | ||
| Female | 14 | 11 | |
| Male | 17 | 9 | |
| WHO status (median) | 2 (1–3) | 2 (1–3) | 0.10 |
| Indication | 0.90 | ||
| Pancreatic adenocarcinoma n (%) | 22 (71) | 15 (75) | |
| Metastatic lymphadenopathy n (%)* | 5 (16) | 2 (10) | |
| Cholangiocarcinoma n (%) | 3 (10) | 2 (10) | |
| Periampullary cancer n (%) | 1 (3) | 1 (5) | |
| Reason for unsuccessful ERCP | 0.89 | ||
| Roux-en-Y n (%) | 13 (42) | 10 (50) | |
| Duodenal stenosis n (%) | 9 (30) | 6 (30) | |
| Periampullary tumor infiltration n (%) | 5 (16) | 2 (10) | |
| Impassable stricture n (%) | 4 (13) | 2 (10) |
*
Colorectal cancer (n = 4), renal cancer (n = 1), lung cancer (n = 1), and ovarian cancer (n = 1).
EU-HGS, endoscopic ultrasound-guided hepaticogastrostomy; PTBD, percutaneous transhepatic biliary drainage; SD, standard deviation; WHO, World Health Organization; ERCP, endoscopic retrograde cholangiopancreatography.